srch

The journal will publish studies that pertain to a broad range of subject matter, including compound design and optimization, biological evaluation, drug ...

Latest Article December 10, 2021. CURRENT ISSUE; VIEW ALL ISSUES; December 10, 2021 ... ACS Medicinal Chemistry Letters, Articles ASAP (Patent Highlight) Publication ...

01.07.2021 · ACS Macro Letters, established in 2012, achieved a Journal Impact Factor™ of 6.903 with 13,599 citations, while ACS Sustainable Chemistry & Engineering, established in 2013, received a Journal Impact Factor™ of 8.198 and 62,273 citations, a …

Scope ; 2017, 1.388 ; 2018, 1.202 ; 2019, 1.158 ; 2020, 1.065 ...

Novel Compounds as PHD Inhibitors for Treating Heart, Lung, Liver, and Kidney Diseases. Ram W. Sabnis*. ACS Medicinal Chemistry Letters 2021, 12, 12, 1868-1869 (Patent Highlight) Publication Date (Web): November 4, 2021. Full text.

ACS Medicinal Chemistry Letters, Articles ASAP (Innovations) Publication Date(Web):December 9, 2021 Abstract Full text PDF ABSTRACT Hepatocellular carcinoma (HCC) is the second or third leading cause of cancer mortality worldwide (depending on which statistics are used), yet there is no effective treatment.

10.11.2015 · ACS Medicinal Chemistry Letters is welcoming submissions for a Special Issue "Epigenetics: Targeting Chromatin- and RNA- Modifications." Submission deadline: December 31, 2021. Read the Editorial to learn more

ACS Medicinal Chemistry Letters ; 2020/2021, -, 4.345 ; 2019, -, 3.975 ; 2018, -, 3.737 ; 2017, -, 3.794 ...

Recent highlights from the journal. antimicrobials illustration. Virtual Issues. Antimicrobials. This Virtual Issue features articles from various ACS journals ...

Journal of Medicinal Chemistry 2021, 64, 21, 15787-15798 (Article) Publication Date (Web): October 27, 2021. Abstract. Full text. PDF. ABSTRACT. Inhibition of TGFβ signaling in concert with a checkpoint blockade has been shown to provide improved and durable antitumor immune response in mouse models.

Discovery of Spirocyclic Androgen Receptor Protein Degraders for the Treatment of Prostate Cancer. Robert B. Kargbo*. ACS Medicinal Chemistry Letters 2021, 12, 11, 1635-1636 (Patent Highlight) Publication Date (Web): October 7, 2021. Full text.

2021: v.12(1): 1–167 2021 Jan 14: v.12(2): 168–308 ... Articles from ACS Medicinal Chemistry Letters are provided here courtesy of American Chemical Society.

Nov 10, 2015 · Epigenetics: Targeting Chromatin- and RNA- Modifications. ACS Medicinal Chemistry Letters is welcoming submissions for a Special Issue "Epigenetics: Targeting Chromatin- and RNA- Modifications." Submission deadline: December 31, 2021. Read the Editorial to learn more.

12 rader · ACS Medicinal Chemistry Letters Impact Factor, IF, number of article, detailed …

ACS Medicinal Chemistry Letters is a monthly peer-reviewed scientific journal covering medicinal chemistry. It was established in 2009 and is published by ...

About the journal ... Bioorganic & Medicinal Chemistry Letters publishes research communications of outstanding significance and timeliness on topics at the ...

Factor de Impact 2020-2021 alACS Medicinal Chemistry Letters este de 4.345 Factor de Impact Analiză, Tendinţă, Clasament & Predicție.

The 2020-2021 Journal Impact IF of ACS Medicinal Chemistry Letters is 4.345, which is just updated in 2021. ACS Medicinal Chemistry Letters Journal Impact IF Highest IF Key Factor Analysis Lowest IF Key Factor Analysis Total Growth Rate Key Factor Analysis Annual Growth Rate Key Factor Analysis ACS Medicinal Chemistry Letters Journal Key Metrics

ACS Medicinal Chemistry Letters ; Index. SCIE/SSCI. Impact Factor. 3.975 · Ranking ; H Index. 66. SJR. 1.065. Scopus Impact Factor ; 2-year. Impact Factor. 3.677. 3 ...

Articles from this journal are generally available in PMC after a 12-month ... ACS Medicinal Chemistry Letters Vols. 1 to 12; 2010 to 2021. Vol. 12 2021 ...